Skip to main content
. 2016 Jun 23;60:10.3402/fnr.v60.30298. doi: 10.3402/fnr.v60.30298

Table 2.

Treatment effect (Δ) on lipid metabolism, insulin, and zinc levels for the test product and the placebo

Test product Placebo
Cholesterol (mg/dl) −6.5 (−43 to 64) 5.5 (−106 to 108)
HDL cholesterol (mg/dl) 1.0 (−9.0 to 31) 0.5 (−9.0 to 8.0)
LDL cholesterol (mg/dl) −5.0 (−47 to 71) 3.0 (−92 to 95)
Triglycerides (mg/dl) −8.5 (−131 to 119) −11.0 (−128 to 360)
Insulin (U/ml) −0.45 (−23 to 9.6) −1.0 (−33 to 15)
Zinc (µg/l) −4.0 (−128 to 78) −1.0 (−38 to 29)

Data are presented as median (range). N=31.